These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34081300)

  • 1. Early Life Antibiotic Exposure and the Subsequent Risk of Autism Spectrum Disorder and Attention Deficit Hyperactivity Disorder: A Systematic Review and Meta-Analysis.
    Yu HY; Zhou YY; Pan LY; Zhang X; Jiang HY
    J Autism Dev Disord; 2022 May; 52(5):2236-2246. PubMed ID: 34081300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs) During Pregnancy and the Risk for Autism spectrum disorder (ASD) and Attention deficit hyperactivity disorder (ADHD) in the Offspring: A True Effect or a Bias? A Systematic Review & Meta-Analysis.
    Leshem R; Bar-Oz B; Diav-Citrin O; Gbaly S; Soliman J; Renoux C; Matok I
    Curr Neuropharmacol; 2021; 19(6):896-906. PubMed ID: 33655866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cesarean section on the risk of autism spectrum disorders/attention deficit hyperactivity disorder in offspring: a meta-analysis.
    Chen M; Lin Y; Yu C; Fu R; Shentu H; Yao J; Huang J; He Y; Yu M
    Arch Gynecol Obstet; 2024 Feb; 309(2):439-455. PubMed ID: 37219611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic use and risk of autism spectrum disorder and attention-deficit/hyperactivity disorder: a population-based cohort study.
    Yang KL; Yen TA; Lin FJ; Hsu CN; Wang CC
    Child Adolesc Psychiatry Ment Health; 2024 Jul; 18(1):82. PubMed ID: 38992772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between prenatal antipsychotic exposure and the risk of attention-deficit/hyperactivity disorder and autism spectrum disorder: a systematic review and meta-analysis.
    Wang Z; Yuen AS; Wong KH; Chan AY; Coghill D; Simonoff E; Lau WC; Wong IC; Park S; Man KK
    Neurosci Biobehav Rev; 2024 May; 160():105635. PubMed ID: 38499117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comment on: "Maternal and Early-Life Exposure to Antibiotics and the Risk of Autism and Attention-Deficit Hyperactivity Disorder in Childhood: A Swedish Population-Based Cohort Study".
    Avó-Baião R; Vareda R; Lopes A
    Drug Saf; 2024 Jul; ():. PubMed ID: 38967836
    [No Abstract]   [Full Text] [Related]  

  • 7. Author's Reply to Avó-Baião et al.'s Comment on "Maternal and Early-Life Exposure to Antibiotics and the Risk of Autism and Attention-Deficit Hyperactivity Disorder in Childhood: A Swedish Population-Based Cohort Study".
    Brusselaers N
    Drug Saf; 2024 Jul; ():. PubMed ID: 38967835
    [No Abstract]   [Full Text] [Related]  

  • 8. Medication Use in the Management of Comorbidities Among Individuals With Autism Spectrum Disorder From a Large Nationwide Insurance Database.
    Feroe AG; Uppal N; Gutiérrez-Sacristán A; Mousavi S; Greenspun P; Surati R; Kohane IS; Avillach P
    JAMA Pediatr; 2021 Sep; 175(9):957-965. PubMed ID: 34097007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of Medication for Attention-Deficit Hyperactivity Disorder in Children and Adolescents with Common Comorbidities: A Systematic Review.
    Tsujii N; Usami M; Naya N; Tsuji T; Mishima H; Horie J; Fujiwara M; Iida J
    Neurol Ther; 2021 Dec; 10(2):499-522. PubMed ID: 34089145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing undertreatment and overtreatment/misuse of ADHD medications in children and adolescents across continents: A systematic review and meta-analysis.
    Massuti R; Moreira-Maia CR; Campani F; Sônego M; Amaro J; Akutagava-Martins GC; Tessari L; Polanczyk GV; Cortese S; Rohde LA
    Neurosci Biobehav Rev; 2021 Sep; 128():64-73. PubMed ID: 34089763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Association of Prenatal Vitamins and Folic Acid Supplement Intake with Odds of Autism Spectrum Disorder in a High-Risk Sibling Cohort, the Early Autism Risk Longitudinal Investigation (EARLI).
    Brieger KK; Bakulski KM; Pearce CL; Baylin A; Dou JF; Feinberg JI; Croen LA; Hertz-Picciotto I; Newschaffer CJ; Fallin MD; Schmidt RJ
    J Autism Dev Disord; 2022 Jun; 52(6):2801-2811. PubMed ID: 34110557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of gut microbiota in autism spectrum disorders and neurotypical boys in China: A case-control study.
    Ye F; Gao X; Wang Z; Cao S; Liang G; He D; Lv Z; Wang L; Xu P; Zhang Q
    Synth Syst Biotechnol; 2021 Jun; 6(2):120-126. PubMed ID: 34095558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cortisol response to acute psychosocial stress in ADHD compared to conduct disorder and major depressive disorder: A systematic review.
    Bernhard A; Mayer JS; Fann N; Freitag CM
    Neurosci Biobehav Rev; 2021 Aug; 127():899-916. PubMed ID: 34089765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the Effects of Pharmacological, Psychosocial, and Alternative/Complementary Interventions in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: Meta-Regression Approach.
    Yang KH; Lane HY; Chang YC; Tzang RF
    Int J Neuropsychopharmacol; 2021 Oct; 24(10):776-786. PubMed ID: 34086891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current use of attention-deficit hyperactivity disorder (ADHD) medications and clinical characteristics of child and adolescent psychiatric outpatients prescribed multiple ADHD medications in Japan.
    Sasaki Y; Tsujii N; Sasaki S; Sunakawa H; Toguchi Y; Tanase S; Saito K; Shinohara R; Kurokouchi T; Sugimoto K; Itagaki K; Yoshida Y; Namekata S; Takahashi M; Harada I; Hakosima Y; Inazaki K; Yoshimura Y; Mizumoto Y; Okada T; Usami M
    PLoS One; 2021; 16(6):e0252420. PubMed ID: 34081716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of mindfulness-based interventions in attention-deficit/hyperactivity disorder beyond core symptoms: A systematic review, meta-analysis, and meta-regression.
    Oliva F; Malandrone F; di Girolamo G; Mirabella S; Colombi N; Carletto S; Ostacoli L
    J Affect Disord; 2021 Sep; 292():475-486. PubMed ID: 34146899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of methylphenidate on blood pressure, QT-interval, and cardiac output in ADHD diagnosed children: A three months' follow-up study.
    Omidi N; Mojtaba Ghorashi S; Zahedi Tajrishi F; Effatpanah M; Khatami F; Rafie Khorgami M
    Int J Cardiol Heart Vasc; 2021 Jun; 34():100805. PubMed ID: 34141860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal Psychiatric Conditions, Treatment With Selective Serotonin Reuptake Inhibitors, and Neurodevelopmental Disorders.
    Ames JL; Ladd-Acosta C; Fallin MD; Qian Y; Schieve LA; DiGuiseppi C; Lee LC; Kasten EP; Zhou G; Pinto-Martin J; Howerton EM; Eaton CL; Croen LA
    Biol Psychiatry; 2021 Aug; 90(4):253-262. PubMed ID: 34116791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic risk factors for autism-spectrum disorders: a systematic review based on systematic reviews and meta-analysis.
    Wei H; Zhu Y; Wang T; Zhang X; Zhang K; Zhang Z
    J Neural Transm (Vienna); 2021 Jun; 128(6):717-734. PubMed ID: 34115189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An elevated anxiety level among prepubertal autistic boys with non-treatment-seeking functional gastrointestinal disorders: A case-control study.
    Wong OWH; Lam AMW; Lai KYC; Ma SL; Hung SF; Chan S; Wong S; Leung PWL
    Autism Res; 2021 Oct; 14(10):2131-2142. PubMed ID: 34114351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.